Omega Healthcare Investors (OHI) FY2016 results: revenue $901 million, up 21.1% on the year
Omega Healthcare Investors Inc. (OHI) reported revenue of $901 million for fiscal 2016, the year ended 31 December 2016, up 21.1% on the year before. Net income was $366 million, up 63.2%, and diluted earnings per share $1.90. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2019.
Revenue
$901 million
+21.1% on the year
FY2009FY2016
Operating margin
62.2%
55.3% a year earlier
FY2009FY2016
Net income
$366 million
+63.2% on the year
FY2009FY2016
Diluted EPS
$1.90
+47.3% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
901
744
505
+21.1%
Operating income
560
411
345
+36.2%
Operating margin
62.2%
55.3%
68.4%
Interest expense
164
147
119
+11.3%
Pre-tax income
384
235
221
+63.9%
Income tax
1.4
1.2
n/a
+16.0%
Effective tax rate
0.4%
0.5%
n/a
Net income
366
225
221
+63.2%
Net margin
40.7%
30.2%
43.8%
Diluted EPS
$1.90
$1.29
$1.74
+47.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
626
464
338
+34.9%
Capital expenditure
40.5
26.4
17.9
+53.3%
Free cash flow
585
437
320
+33.8%
Free cash flow margin
65.0%
58.8%
63.3%
Cash from investing
-1,114
-397
-548
Cash from financing
576
-65.3
212
Depreciation and amortisation
267
211
123
+26.7%
Share-based compensation
13.8
11.1
8.6
+23.9%
Dividends paid
453
358
259
+26.5%
Dividend per share
$2.36
$2.18
$2.02
+8.3%
Diluted shares, weighted
202m
181m
127m
+11.7%
Shares outstanding at period end
196m
187m
128m
+4.7%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
3,859
3,738
1,401
+3.2%
Non-controlling interest
353
363
n/a
-2.7%
Debt
4,367
3,569
2,379
+22.4%
Other liabilities
370
320
142
+15.8%
Total liabilities and equity
8,949
7,990
3,922
+12.0%
Goodwill
643
646
n/a
-0.3%
Cash and equivalents
93.7
5.4
4.5
+1,627.3%
Other assets
8,212
7,339
3,917
+11.9%
Total assets
8,949
7,990
3,922
+12.0%
10-K for the year ended 31 December 2016, filed 26 February 2019: the filing.